Arrowhead Pharmaceuticals breaks ground on Verona expansion Sean Kirkby 3 years ago Arrowhead Pharmaceuticals, a genetic medicine company, broke ground on its $220 million expansion in Verona on Monday. To access this content, you must purchase a Premium membership, or log in if you are a member.